Editor's highlight

Professor Hans Evers, Editor-in-Chief of Human Reproduction, casts his eye over the current issue of Human Reproduction and selects his own highlight.

Editor's comment

BREAKING NEWS: Individualised FSH dosing for IVF does not improve live birth rates

This month, in three episodes, we publish the results of the OPTIMIST study, the latest production of the Dutch Consortium for Healthcare Evaluation and Research in Obstetrics and Gynecology. The findings are important:

JLH (Hans) Evers, Editor-in-Chief Human Reproduction

Reference

Theodora C van Tilborg Simone C Oudshoorn Marinus J C Eijkemans Monique H Mochtar Ron J T van Golde Annemieke Hoek Walter K H Kuchenbecker Kathrin Fleischer Jan Peter de Bruin Henk Groen Madelon van Wely Cornelis B Lambalk Joop S E Laven Ben Willem J Mol Frank J M Broekmans Helen L Torrance on behalf of the OPTIMIST study group

Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis

Hum Reprod (2017) 32 (12): 2485-2495  DOI: https://doi.org/10.1093/humrep/dex321

Theodora C van Tilborg Helen L Torrance Simone C Oudshoorn Marinus J C Eijkemans Carolien A M Koks Harold R Verhoeve Annemiek W Nap Gabrielle J Scheffer A Petra Manger Benedictus C Schoot Alexander V Sluijmer Arie Verhoeff Henk Groen Joop S E Laven Ben Willem J Mol Frank J M Broekmans on behalf of the OPTIMIST study group

Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder

Human Reprod (2017) 32 (12): 2496–2505 DOI: https://doi.org/10.1093/humrep/dex318

Simone C Oudshoorn Theodora C van Tilborg Marinus J C Eijkemans G Jur E Oosterhuis Jaap Friederich Marcel H A van Hooff Evert J P van Santbrink Egbert A Brinkhuis Jesper M J Smeenk Janet Kwee Corry H de Koning Henk Groen Cornelis B Lambalk Ben Willem J Mol Frank J M Broekmans Helen L Torrance on behalf of the OPTIMIST study group

Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder

Human Reprod (2017) 32 (12): 2506–2514 DOI: https://doi.org/10.1093/humrep/dex319